Doctor profile · Federal record
Dr. Maria Linares Valderrama, M.D.
Endocrinology, Diabetes & Metabolism Physician (CMS: Endocrinology) · Pasadena, CA
- NPI 1659739324
- Accepts Medicare
- MIPS 74.5 / 100 · 2023
- 15 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
675 S Arroyo Pkwy Ste 200
Pasadena, CA 911053215
(626) 585-4121 - Mailing address
-
Po Box 35380
Las Vegas, NV 891335380
Credentials & registration
- NPI registered
- February 2016 — 10 yrs on file
- Profile last updated
- March 9, 2026
- Year of graduation
- 2011 — 15 yrs since
- Specialty taxonomy
- 207RE0101X — NUCC code
- State license (1)
- California #A160352
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1659739324. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
189
Distinct HCPCS
6
Medicare allowed
$20,110
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 52 | 30 | $138 | |
82962 |
Blood glucose (sugar) test performed by hand-held instrument | 41 | 19 | $3 | |
99205 |
New patient office or other outpatient visit, 60-74 minutes | 32 | 32 | $237 | |
G0447 |
Face-to-face behavioral counseling for obesity, 15 minutes | 30 | 16 | $27 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 21 | 15 | $99 | |
99204 |
New patient office or other outpatient visit, 45-59 minutes | 13 | 13 | $180 |
In context: peer comparison
Among 4 peers in Pasadena Endocrinology, Diabetes & Metabolism Physician, average services per provider: 1,147. This provider delivers 0.2× the peer median.Open Payments
Industry payments received
All-time total
$1,458
Transactions
64
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Novo Nordisk INC | 19 | $308.26 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | 8 | $218.35 | |
| Bayer Healthcare Pharmaceuticals INC. | 7 | $184.55 | |
| Lilly USA, LLC | 6 | $145.71 | |
| Xeris Pharmaceuticals, INC. | 4 | $96.93 | |
| Mannkind Corporation | 4 | $82.81 | |
| Madrigal Pharmaceuticals | 2 | $74.58 | |
| Medtronic, INC. | 3 | $66.81 | |
| Ascensia Diabetes Care US INC. | 2 | $45.19 | |
| Dexcom, INC. | 2 | $41.39 | |
| Corcept Therapeutics | 2 | $40.18 | |
| Ibsa Pharma INC. | 2 | $39.59 | |
| Sanofi-Aventis U.S. LLC | 1 | $28.96 | |
| Recordati_Rare_Diseases_INC. | 1 | $28.68 | |
| Insulet Corporation | 1 | $20.14 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
1,644
Patients
611
Total drug cost
$1,133,579
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Jardiance (Empagliflozin) | Brand | 233 | 87 | $316,546 |
| Metformin Hcl | Generic | 225 | 91 | $3,680 |
| Atorvastatin Calcium | Generic | 183 | 77 | $4,575 |
| Ozempic (Semaglutide) | Brand | 154 | 52 | $179,539 |
| Trulicity (Dulaglutide) | Brand | 111 | 37 | $148,266 |
| Lantus Solostar (Insulin Glargine,Hum.Rec.Anlog) | Brand | 102 | 32 | $63,890 |
| Rybelsus (Semaglutide) | Brand | 101 | 28 | $154,215 |
| Farxiga (Dapagliflozin Propanediol) | Brand | 94 | 28 | $95,357 |
| Glipizide | Generic | 82 | 42 | $1,110 |
| Pioglitazone Hcl | Generic | 75 | 36 | $1,846 |
Frequently asked questions
What is Dr. Maria Linares Valderrama's medical specialty?
Dr. Maria Linares Valderrama practices Endocrinology, Diabetes & Metabolism Physician in Pasadena, CA.
Where does Dr. Maria Linares Valderrama practice?
Dr. Maria Linares Valderrama practices at 675 S Arroyo Pkwy Ste 200, Pasadena, CA 911053215. Office phone: 6265854121.
What is Dr. Maria Linares Valderrama's NPI?
Dr. Maria Linares Valderrama's National Provider Identifier (NPI) is 1659739324, issued by NPPES.
Does Dr. Maria Linares Valderrama accept Medicare assignment?
Yes. Dr. Maria Linares Valderrama accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Maria Linares Valderrama commonly perform?
Top Medicare-reported procedures in 2023: Established patient office or other outpatient visit (HCPCS 99214); Blood glucose (sugar) test performed by hand-held instrument (HCPCS 82962); New patient office or other outpatient visit (HCPCS 99205). Source: CMS Medicare Physician & Other Practitioners file.